Table 1.
IEC Agent Variable | Description | Effect in IVSABM |
---|---|---|
EGFR | Membrane-bound receptor | Binds EGF, leads to effectors of motility, cell spreading |
TLR-4 | Membrane-bound receptor | Binds DAMPs/ROS, activates MEK/ERK pathway |
P2Y | Membrane-bound receptor | Binds ATP, activates PLC/PKC pathway |
A2B | Membrane-bound receptor | Binds adenosine, activates PI3K pathway |
TGF-β-R | Membrane-bound receptor; available only in absence of tight junctions |
Binds TGF-β, leads to LM-332 deposition in SECM |
Integrin-α3β1 | Membrane-bound receptor; induced by wounding |
Binds LM-332, activates Rac1 |
Integrin-α6β4 | Membrane-bound receptor | Binds LM−511, activates RhoA |
CD73 | Membrane-bound receptor; upregulated 10-fold by HIF-1α |
Converts ATP to adenosine |
Intracellular kinases (MEK, ERK, PLC, PKC, PI3K, Src, Akt, SMAD) |
Signaling intermediates | Lead to various pathways and effector molecules |
HIF−1α | Transcription factor; induced by hypoxia |
Upregulation of CD73 |
NFκB | Transcription factor | Leads to EGFR expression |
ADAM-17 | Metalloprotease | Releases membrane-bound EGF into media |
FAK/Paxillin | Effectors | Form a complex to induce simulated lamellopodial protrusion |
mTOR | Effector | Cell spreading |
Rac1 | Effector; induced by integrin- α3β1 |
Pro-motility |
RhoA | Effector; induced by integrin- α6β4 |
Pro-stability |